DOTCHIN & ASSOCIATES, LLC for EMERGENT BIOSOLUTIONS
What was lobbied
5 issue areas, each in the filer's own words, with who lobbied on it and where.
Defense DEF
NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Disaster Planning/Emergencies DIS
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Health Issues HCR
FDA regulatory issues Issues related to Priority Review Voucher programs Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act), FY 2021 and Covid-19 next supplemental provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government State Opioid Response Grants funding for FY 2021 Emergency Support for Substance Use Disorders Act/ Legislation to create emergency grants for states and community-based organizations that serve individuals with substance use disorder Opioid and heroin addiction legislation, naloxone access and awareness and opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Budget/Appropriations BUD
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense Department of Defense appropriations for Medical Countermeasures H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Homeland Security HOM
FY 2020 Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government Re-authorization of the Pandemic and All-Hazards Preparedness Act NDAA - provisions related to biological and chemical defense H.R.6074 - Coronavirus Preparedness and Response Supplemental Appropriations Act of 2020, S.3548 - CARES Act, FY 2021 Appropriations provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. Government NDAA - provisions related to biological and chemical defense Issues related to Priority Review Voucher programs Opioid and heroin addiction legislation, naloxone access, co- prescribing/opioid prescribing guidelines
| Lobbyist | Covered position, as disclosed |
|---|---|
| ROBERT J. DOTCHIN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.